In addition, Pan et al recently have developed an anti‐MUC1 antibody‐drug conjugate synthesized by conjugating GSTA neoantigen‐specific 16A with monomethyl auristatin E (MMAE), which displaying potent antitumoural efficacy towards various cancer cells including NSCLC.39 Here, MUC1 is linked to cancer.